
Efficacy and Safety of Lebrikizumab in Moderate-to-Severe Atopic Dermatitis: Results from Two Phase 3, Randomized, Double-Blinded, Placebo-Controlled Trials
Authors: Jonathan I. Silverberg, Diamant Thaçi, Julien Seneschal, Linda Stein Gold, Andrew Blauvelt, Eric Simpson, Chia-Yu Chu, Zhuqing T. Liu, Renata Gontijo Lima, Sreekumar Pillai, Emma Guttman-Yassky